Arkolith/Insider Trading/AXSM/Form 4

Coleman Mark

DirectorAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Feb 23, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 20, 2026Option exercise(M)12K$4.95$62K66K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 20, 2026Option exercise(M)12K—$014K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-064681) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML